Citation: | MA Chenglei, ZHANG Yajie, TONG Jianye, YAN Hongchao. Expression of miR-146b-5p and TRIM29 in endometrial carcinoma[J]. Journal of Xuzhou Medical University, 2023, 43(1): 59-64. DOI: 10.3969/j.issn.2096-3882.2023.01.011 |
[1] |
Lu KH,Broaddus RR.Endometrial cancer.reply[J].N Engl J Med,2021,384(6):586.
|
[2] |
Straubhar AM,Parsons MW,Francis S,et al.Refusal of surgery and survival outcomes in endometrial cancer[J].Int J Gynecol Cancer,2021,31(9):1236-1241.
|
[3] |
Lortet-Tieulent J,Ferlay J,Bray F,et al.Internationalpatterns and trends in endometrial cancer incidence,1978-2013[J].J Natl Cancer Inst,2018,110(4):354-361.
|
[4] |
Bartel DP.Metazoan microRNAs[J].Cell,2018,173(1):20-51.
|
[5] |
Tan WG,Liu BD,Qu SH,et al.MicroRNAs and cancer:key paradigms in molecular therapy[J].Oncol Lett,2018,15(3):2735-2742.
|
[6] |
Li YW,Zhang HB,Dong YL,et al.MiR-146b-5p functions as a suppressor miRNA and prognosis predictor in non-small cell lung cancer[J].J Cancer,2017,8(9):1704-1716.
|
[7] |
Jiang K,Li GP,Chen WJ,et al.Plasma exosomal miR-146b-5p and miR-222-3p are potential biomarkers for lymph node metastasis in papillary thyroid carcinomas[J].Onco Targets Ther,2020,13:1311-1319.
|
[8] |
Santa-Inez DC,Fuziwara CS,Saito KC,et al.Targeting the highly expressed microRNA miR-146b with CRISPR/Cas9n gene editing system in thyroid cancer[J].Int J Mol Sci,2021,22(15):7992.
|
[9] |
Huang XH,Zhong R,He XK,et al.Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling[J].IUBMB Life,2019,71(2):223-234.
|
[10] |
Luo SX,Shen M,Chen H,et al.Long non-coding RNA TP73-AS1 accelerates the progression and cisplatin resistance of non-small cell lung cancer by upregulating the expression of TRIM29 via competitively targeting microRNA-34a-5p[J].Mol Med Rep,2020,22(5):3822-3832.
|
[11] |
Hatakeyama S.Early evidence for the role of TRIM29 in multiple cancer models[J].Expert Opin Ther Targets,2016,20(7):767-770.
|
[12] |
Yin XD,Zhang J,Li CJ,et al.LncRNA HOXA11-AS accumulation-induced microRNA-761 downregulation regulates cell growth by targeting TRIM29 in papillary thyroid cancer[J].Am J Transl Res,2019,11(11):6826-6837.
|
[13] |
Xu MX,Hu JX,Zhou BX,et al.TRIM29 prevents hepatocellular carcinoma progression by inhibiting Wnt/β-catenin signaling pathway[J].Acta Biochim Biophys Sin (Shanghai),2019,51(1):68-77.
|
[14] |
Qiao HY,Zhang Q,Wang JM,et al.TRIM29 regulates the SETBP1/SET/PP2A axis via transcription factor VEZF1 to promote progression of ovarian cancer[J].Cancer Lett,2022,529:85-99.
|
[15] |
Gentry-Maharaj A,Karpinskyj C.Current and future approaches to screening for endometrial cancer[J].Best Pract Res Clin Obstet Gynaecol,2020,65:79-97.
|
[16] |
Qiu ZW,Li H,Wang JW,et al.MiR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma[J].Oncol Rep,2017,38(5):2735-2740.
|
[17] |
Xu JK,Li ZY,Su QH,et al.Suppression of long noncoding RNA LINC00324 restricts cell proliferation and invasion of papillary thyroid carcinoma through downregulation of TRIM29 via upregulating microRNA-195-5p[J].Aging (Albany NY),2020,12(24):26000-26011.
|
[18] |
Zhang ZM,Fu XL,Gao YY,et al.LINC01535 attenuates ccRCC progression through regulation of the miR-146b-5p/TRIM2 axis and inactivation of the PI3K/Akt pathway[J/OL].J Oncol,2022,2022:2153337.
|